Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCLS Holdings Regulatory News (CLI)

Share Price Information for CLS Holdings (CLI)

Share Price is delayed by 15 minutes
Get Live Data
50.20    0.00 (0.00%)
Bid:
49.15
Ask:
51.20
Spread: 2.05 (4.171%)
Market Cap: £199.85m
CLI Live PriceLast checked at - London Stock Exchange

Intraday CLS Holdings Share Chart

Board Change

27 Nov 2008 15:30

CLS HOLDINGS PLC ("CLS" or "the Company") BOARD CHANGES

The Board of CLS Holdings plc is pleased to announce the appointment of Mr Joseph Crawley and Mr Chris Jarvis as Non-executive Directors with immediate effect.

In addition, Mr James Dean is to retire on 31st December 2008 as a Non-executive Director after over nine years of valuable service. James has also made an important contribution as a member of both the Audit Committee and of the Remuneration Committee, of which he was Chairman. Thomas Lundqvist and Joseph Crawley will be appointed as Chairman and Member of the Remuneration Committee respectively, Chris Jarvis will be appointed as a member of the Audit Committee and Malcolm Cooper will replace James as the Senior Independent Director. These committee changes are expected to take effect on 31st December 2008.

Joseph Crawley is Chief Executive of Kitewood Estates Ltd, a property investment and development company active in London and south-east England. Kitewood specialises in supplying residential property to housing associations and also has a commercial business which is developing a business park in Kent. Joe has considerable experience, knowledge and contacts relating to the central London property market and has been active in property development in the London area for over 20 years. He was previously employed by CLS from 1988 to 1991 when he was responsible for property development, including the development of the Spring Gardens site. He was CLS' Development Director from 1995 to September 1999.

Chris Jarvis FRICS is senior partner of Jarvis & Partners, a boutique real estate consultancy that he established in Berlin in 1994. Jarvis & Partners acquired a leading role in advising major tenants and owner occupiers in Germany with a client list including Linklaters, Clifford Chance and the European Central Bank. Jarvis & Partners' work has been involved in advising a number of German equity investors and working with German based international corporates on sale and leaseback deals in Europe. Prior to establishing Jarvis & Partners, Chris worked for Richard Ellis for 13 years in London and Germany, from 1988 to 1994 as Managing Director of Richard Ellis Germany.

Sten Mortstedt, Chairman, commented:

"We are delighted that Joe and Chris have agreed to join the Board. The Board thanks James for all he has done for CLS and wishes him well for the future."

Pursuant to Listing Rule 9.6.13 (3) Joseph Allen Crawley was an Executive Director of Groveclose Ltd which was voluntarily liquidated in 2001 and he resigned as a Director of Trinity Modular Technology Ltd on 1 October 1995 which was later put into liquidation in July 1996. No further information is required to be disclosed pursuant to LR 9.6.13 R. Joe does not have any beneficial interests in CLS ordinary shares.

No information is required to be disclosed pursuant to LR 9.6.13 R in respect of Christopher Patrick Jarvis and he does not have any beneficial interests in CLS ordinary shares.

Enquiries:

Sten Mortstedt, Executive Chairman, CLS Holdings plc +44 (0) 20 7582 7766

Henry Klotz, Chief Executive Officer, CLS Holdings plc +44 (0) 20 7582 7766

vendor
Date   Source Headline
6th May 20206:15 pmRNSDirector/PDMR Shareholding
1st May 202012:13 pmRNSDirector/PDMR Shareholding
29th Apr 202011:21 amRNSDisclosure of rights attached to equity shares
23rd Apr 20205:16 pmRNSResult of AGM
23rd Apr 202012:14 pmRNSResult of AGM
23rd Apr 202012:12 pmRNSAppointment of Senior Independent Director
14th Apr 20203:24 pmRNSDirector/PDMR Shareholding
9th Apr 20204:35 pmRNSPrice Monitoring Extension
8th Apr 20207:00 amRNSTrading Statement
6th Apr 20205:36 pmRNSDirector/PDMR Shareholding
1st Apr 20204:36 pmRNSPrice Monitoring Extension
27th Mar 20206:06 pmRNSDirector/PDMR Shareholding
24th Mar 20201:50 pmRNSDirector/PDMR Shareholding
23rd Mar 20204:42 pmRNSAnnual Financial Report
23rd Mar 20203:09 pmRNSDirector/PDMR Shareholding
20th Mar 20205:14 pmRNSDirector/PDMR Shareholding
20th Mar 202010:15 amRNSPrice Monitoring Extension
19th Mar 20204:41 pmRNSSecond Price Monitoring Extn
19th Mar 20204:37 pmRNSPrice Monitoring Extension
18th Mar 20208:24 amRNSDirector/PDMR Shareholding
12th Mar 20205:22 pmRNSDirector/PDMR Shareholding
10th Mar 20208:53 amRNSDirector/PDMR Shareholding
6th Mar 20205:31 pmRNSDirector/PDMR Shareholding
5th Mar 20207:00 amRNSFinal Results
24th Feb 20207:00 amRNSNotice of Results
17th Feb 202010:26 amRNSHolding(s) in Company
12th Feb 20202:14 pmRNSDirector/PDMR Shareholding
4th Feb 20206:14 pmRNSNotification of change in a Director's details
23rd Jan 20205:13 pmRNSDirector/PDMR Shareholding
14th Jan 20204:47 pmRNSDirector/PDMR Shareholding
8th Jan 20207:00 amRNSAcquisition
31st Dec 20197:00 amRNSSale of the UK regional office portfolio
11th Dec 20195:16 pmRNSDirector/PDMR Shareholding
21st Nov 20197:00 amRNSTrading Statement
20th Nov 20197:00 amRNSAppointment of independent Non-Executive Director
13th Nov 20197:00 amRNSAcquisition
8th Nov 20194:07 pmRNSDirector/PDMR Shareholding
17th Oct 20194:53 pmRNSDirector/PDMR Shareholding
14th Oct 20197:00 amRNSAcquisition
11th Oct 20195:03 pmRNSDirector/PDMR Shareholding
3rd Oct 20197:00 amRNSAcquisition
6th Sep 20195:41 pmRNSDirector/PDMR Shareholding
3rd Sep 20197:00 amRNSShareholding in Catena AB
2nd Sep 20194:31 pmRNSShareholding in Catena AB
14th Aug 20194:05 pmRNSDirector/PDMR Shareholding
14th Aug 20197:00 amRNSHalf-year Report
8th Aug 20199:09 amRNSDirector/PDMR Shareholding
5th Aug 20195:06 pmRNSNotice of Half Year Results
22nd Jul 20198:03 amRNSCLS announces sales in Munich and Dusseldorf
17th Jul 201911:29 amRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.